3P Biopharmaceuticals: building a legacy of innovation and excellence in biotechnology
News and updates
Corporate News & Press Releases
Biovian announces the successful refinancing of its existing debt package and the securing of new funding to support GeneCity facility expansion
Biovian Unveils the Stonemasonry Work of GeneCity Facility
Biovian announces over €50 million investment in manufacturing facility in Turku, Finland
3P Biopharmaceuticals lands in the United States.
The Regional Minister for Economic and Business Development Mikel Irujo meets with the management of 3P Biopharmaceuticals and its majority shareholder Keensight Capital.
3P Biopharmaceuticals is moving forward with its expansion plan and the adaptation of its facilities.
3P Biopharmaceuticals increases its microbial production capacity with the installation of a 500 L fermenter.
3P Biopharmaceuticals among the 500 fastest growing companies in Spain
3P Biopharmaceuticals brings together leading international experts in biomedicine to celebrate its 15th anniversary.
3P Biopharmaceuticals among the 100 best companies to work for in Spain
Biovian Announces the Appointment of a New Board Member − Dr. Uwe Gottschalk
3P Biopharmaceuticals celebrates its 15th anniversary with Juan Carlos Unzué.
3P Biopharmaceuticals awards prize for the best Final Degree Project in Pharmacy at the University of Navarra
3P Biopharmaceuticals makes a significant donation to help Ukraine
Dámaso Molero, appointed member of the Technical Committee of the Interdepartmental Commission for Personalized Medicine of Navarra.